The new Antibody Developability Consortium will pool proprietary data without exposing members’ sequences, aiming to improve ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, ...
Innovent Biologics, Inc. announced updated Phase 1 clinical data for IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA, and CD3, in patients with relapsed or refractory multiple myeloma ...
FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases HONG KONG and SHANGHAI and ...
OpenAI-backed Nabla Bio's JAM-2 AI model designs antibodies ready for human trials, potentially revolutionizing drug ...
Peanut allergy is one of the most serious food allergies and can lead to sudden, life-threatening reactions. Researchers from ...
Lung cancer remains the deadliest malignancy worldwide, and non-small cell lung cancer (NSCLC) accounts for roughly 85 ...
Blood plasma has long been the workhorse of clinical diagnostics, a fluid so rich in molecular information that a single draw ...
XtalPi (HKEX: 2228), an AI- and robotics-driven drug and materials discovery company, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug ...
Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member of the Roche Group, to discover and develop ...
Earendil Labs announced on September 24, 2026, a research collaboration with Genentech, a member of the Roche Group, to discover and develop multiple bispecific antibody therapies for cancer. The ...
Learning the Lymphatic System and Immune Tissues in Histology—A Defense Network Spread Throughout the BodyOur bodies are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results